Open Access

[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway

  • Authors:
    • Meijuan Chen
    • Cheng Hu
    • Yuanyuan Guo
    • Rilei Jiang
    • Huimin Jiang
    • Yu Zhou
    • Haian Fu
    • Mianhua Wu
    • Xu Zhang
  • View Affiliations

  • Published online on: July 10, 2024     https://doi.org/10.3892/or.2024.8774
  • Article Number: 115
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

September-2024
Volume 52 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen M, Hu C, Guo Y, Jiang R, Jiang H, Zhou Y, Fu H, Wu M and Zhang X: [Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells <em>in vitro</em> and <em>in vivo</em> by inhibiting the EphA2/Akt signaling pathway. Oncol Rep 52: 115, 2024.
APA
Chen, M., Hu, C., Guo, Y., Jiang, R., Jiang, H., Zhou, Y. ... Zhang, X. (2024). [Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells <em>in vitro</em> and <em>in vivo</em> by inhibiting the EphA2/Akt signaling pathway. Oncology Reports, 52, 115. https://doi.org/10.3892/or.2024.8774
MLA
Chen, M., Hu, C., Guo, Y., Jiang, R., Jiang, H., Zhou, Y., Fu, H., Wu, M., Zhang, X."[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells <em>in vitro</em> and <em>in vivo</em> by inhibiting the EphA2/Akt signaling pathway". Oncology Reports 52.3 (2024): 115.
Chicago
Chen, M., Hu, C., Guo, Y., Jiang, R., Jiang, H., Zhou, Y., Fu, H., Wu, M., Zhang, X."[Corrigendum] Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells <em>in vitro</em> and <em>in vivo</em> by inhibiting the EphA2/Akt signaling pathway". Oncology Reports 52, no. 3 (2024): 115. https://doi.org/10.3892/or.2024.8774